In conclusion, we describe a tumor suppressor role of miR-100 and miR-125b in association with CSCs of HCC that involves the inhibition of IGF2 expression and resultant suppression of the IGF2-mediated PI3K/AKT/mTOR pathway. The gene discussed is IGF2; the disease is hepatocellular carcinoma.